1. Home
  2. SAGE vs ALT Comparison

SAGE vs ALT Comparison

Compare SAGE & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • ALT
  • Stock Information
  • Founded
  • SAGE 2010
  • ALT 1997
  • Country
  • SAGE United States
  • ALT United States
  • Employees
  • SAGE N/A
  • ALT N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAGE Health Care
  • ALT Health Care
  • Exchange
  • SAGE Nasdaq
  • ALT Nasdaq
  • Market Cap
  • SAGE 462.2M
  • ALT 457.0M
  • IPO Year
  • SAGE 2014
  • ALT N/A
  • Fundamental
  • Price
  • SAGE $5.17
  • ALT $8.68
  • Analyst Decision
  • SAGE Hold
  • ALT Buy
  • Analyst Count
  • SAGE 20
  • ALT 7
  • Target Price
  • SAGE $12.83
  • ALT $20.00
  • AVG Volume (30 Days)
  • SAGE 958.4K
  • ALT 4.3M
  • Earning Date
  • SAGE 10-29-2024
  • ALT 11-12-2024
  • Dividend Yield
  • SAGE N/A
  • ALT N/A
  • EPS Growth
  • SAGE N/A
  • ALT N/A
  • EPS
  • SAGE N/A
  • ALT N/A
  • Revenue
  • SAGE $106,399,000.00
  • ALT $52,000.00
  • Revenue This Year
  • SAGE N/A
  • ALT N/A
  • Revenue Next Year
  • SAGE $118.26
  • ALT N/A
  • P/E Ratio
  • SAGE N/A
  • ALT N/A
  • Revenue Growth
  • SAGE 837.60
  • ALT N/A
  • 52 Week Low
  • SAGE $4.62
  • ALT $2.50
  • 52 Week High
  • SAGE $28.26
  • ALT $14.84
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 35.68
  • ALT 60.55
  • Support Level
  • SAGE $4.62
  • ALT $6.95
  • Resistance Level
  • SAGE $5.87
  • ALT $9.06
  • Average True Range (ATR)
  • SAGE 0.40
  • ALT 0.94
  • MACD
  • SAGE -0.07
  • ALT 0.05
  • Stochastic Oscillator
  • SAGE 27.09
  • ALT 45.13

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: